Semiquantitative Assessment of Tumor Spread Through Air Spaces (STAS) in Early-Stage Lung Adenocarcinomas
Overview
Pulmonary Medicine
Affiliations
Introduction: Tumor spread through air spaces (STAS) has recently been reported as a form of tumor invasion having an unfavorable prognosis, but the significance of a small amount of STAS is not known. The aim of this study was to perform a semiquantitative assessment of STAS.
Methods: Small (≤2 cm) stage I lung adenocarcinomas surgically resected at our institution between 2003 and 2009 were assessed semiquantitatively in the most prominent area as no STAS, low STAS (1-4 single cells or clusters of STAS), or high STAS (≥5 single cells or clusters of STAS) by using a 20× objective and a 10× ocular lens. A statistical analysis was performed to determine the impact of clinicopathologic parameters on STAS and to clarify the relationship between STAS and patient survival.
Results: STAS was assessed as no STAS in 109 of 208 cases (52.4%), as low STAS in 38 cases (18.3%), and as high STAS in 61 cases (29.3%). There were statistically significant associations between higher STAS and solid predominant invasive adenocarcinoma (p < 0.001), pleural invasion (p < 0.001), lymphatic invasion (p < 0.001), vascular invasion (p < 0.001), and tumor size of 10 mm or more (p = 0.037). There was a significant association between increasing STAS and shorter recurrence-free survival (RFS) in univariate analysis (no STAS, 154.2 months; low STAS, 147.6 months; and high STAS, 115.6 months). In a multivariate Cox proportional hazards model, only STAS (p = 0.015) remained a significant predictor of RFS.
Conclusions: We found that one-third of resected small adenocarcinomas had high STAS. Higher STAS was predictive of worse RFS.
Research hotspots and trends in lung cancer STAS: a bibliometric and visualization analysis.
Peng X, Bian H, Zhao H, Jia D, Li M, Li W Front Oncol. 2025; 14():1495911.
PMID: 39830648 PMC: 11739358. DOI: 10.3389/fonc.2024.1495911.
Chen J, Zhu Y, Liu B, Ma H, Li L, Chen M J Thorac Dis. 2024; 16(11):7244-7256.
PMID: 39678835 PMC: 11635242. DOI: 10.21037/jtd-24-724.
Zhang X, Qiao W, Shen J, Jiang Q, Pan C, Wang Y Transl Lung Cancer Res. 2024; 13(10):2802-2812.
PMID: 39507029 PMC: 11535835. DOI: 10.21037/tlcr-24-715.
Isgir B, Kocaman G, Kahya Y, Ozakinci H, Elhan A, Yuksel C Updates Surg. 2024; 77(1):201-208.
PMID: 39488820 DOI: 10.1007/s13304-024-02000-4.
Almeida G, Pinto B, Pinto V, Tregnago A, Almeida R, Pinto Filho D J Bras Pneumol. 2024; 50(4):e20240165.
PMID: 39356913 PMC: 11449603. DOI: 10.36416/1806-3756/e20240165.